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1. Introduction 
Skin transplants have long been of interest to plastic surgeons for the treatment of burns and 
other wounds. Skin transplants provide a better micro-enviromental for wound healing and 
provide physiological barrier which greatly decreases water, electrolyte, protein and heat 
loss through the wound. However, skin grafts are not always available in adequate 
quantities for the complete duration of treatment, making skin graft preservation important 
in meeting the need for skin transplantation. 
This chapter highlights progress in the field of skin graft preservation including basic 
knowledge of skin preservation, harvesting, processing and preservation, and quality 
control methods and is intended to provide a reference for skin preservation techniques for 
doctors and researchers. 
2. Thermal physics of skin low-temperature preservation 
The low-temperature preservation with viable cells and tissues is a complicated procedure, 
which needs to undergo multiple processes including pretreatment, freezing, preservation 
under low temperature and thawing in proper order. In these processes, there is 
unavoidably evident change in the functions and morphology of the tissues. An ideal 
preservation procedure should be that viable cells and tissues can restore to the original 
functions and morphology prior to preservation after undergoing all of these processes and 
then be used for grafting and other purposes like fresh cells and tissue. So far, the effect of 
low-temperature preservation does not meet the above ideal conditions. Also, doctors and 
researchers are not fully aware of the change in viable tissue in the preservation processes, 
especially in the processes of freezing and thawing.  
Water occupies a considerable proportion ofviable cells and tissues. The moisture content of 
skin is about 70%. The quality of skin is closely related to the phase transition of water 
during low-temperature preservation, which including the solidification in freezing, 
ebullition in freezing of viable tissue using liquid nitrogen, thawing during freezing and so 
on.  
Water or water vapor can generate more than 10 kinds of solid phase structure, 
nevertheless, most of them need to be formed under high pressure environment (at least 200 
million Pascal˄Mpa˅), and only hexagonal ice, cube ice or amorphous ice can be 
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generated under low pressure. Water vapor deposits on a cold surface within the 
temperature range from 0Ԩ slightly below to about -80Ԩ, or forms a hexagonal symmetric 
ice crystal in a suspended state in the air, snow is a typical case in point, and cubic crystal 
with diamond structure will be generated under lower temperature (about -80Ԩ~-130Ԩ) 
and amorphous solid (also called glassy, vitrification) will be formed below -140Ԩ. Liquid 
water usually only forms a hexagonal symmetric ice crystal upon freezing, however, 
solutes-bearing water solution more easily realizes vitrification upon freezing compared 
with pure water. Therefore, some components shall be added before freezing, in order to 
promote the suspension of cells or tissues to more easily reach vitrification (Zhu et al., 
2002).  
It is generally believed that there are two kinds of cell damaged in the freezing process: one 
is intracellular ice crystals damage and the other is solution damage. Ice crystals cause the 
change of cell wall and ultra-structures in the cells. Even death can occur by intracellular ice 
crystals growing to a certain degree during freezing. This damage is more serious in the case 
of quicker freezing. Solution damage causes cell damage by extracellular high-concentration 
solution because water freezes outside of the cells. The longer cells stay in high-
concentration solution, the more serious the solution damage is. For certain types of cells 
and freezing processes, ice crystals and solution damage exist simultaneously; nevertheless, 
solution damage dominates in the case of slow cooling and intracellular ice damage 
dominates in the case of quick cooling. And the solution damage and intracellular ice 
damage shall be avoided or reduce if ice crystals are avoided (e.g. amorphous or glassy solid 
are obtained), or ice crystals are formed but fail to grow to change the structure of cells (e.g. 
partly vitrification) in case of snap freezing. 
There are two different protocols used in skin low-temperature preservation: slow freezing 
and quick freezing/snap frozen. Slow freezing reduces the temperature of the skin treated 
with antifreeze fluid from about 4 to -60Ԩ at preset rate (e.g. 1-3Ԩ/min) and balanced for 4h 
using a controlled-rate cooling apparatus, which adopts liquid nitrogen gas to absorb the 
heat of specimen mainly by convective heat transfer, and then put skin into liquid nitrogen 
for preservation. It is worthy of note that, the moisture contained in those tissues with 
greater mass will releases a large amount of latent heat in a cold room at near 0Ԩ, however, 
liquid nitrogen gas can’t rapidly absorb the latent heat of water phase transition due to 
lower convective heat transfer coefficient, so it makes a probable great difference between 
the displayed temperature by a controlled-rate cooling apparatus and the actual 
temperature in the skin tissues, and it is difficult to reduce this temperature difference by 
increasing cold gas volume. In case of snap frozen, the skin is incubated with antifreeze 
solution and then transferred directly to liquid nitrogen, and the temperature can be cooled 
from >0Ԩ to liquid nitrogen temperature within 30s. Being simple, snap frozen eliminates 
special instrument and reduces cost. However, liquid nitrogen may generate grave 
ebullition during snap freezing, and the big temperature difference between liquid nitrogen 
and skin can not be fully utilized at the initial stage of freezing, thus, “thermo-zone 
platform” (as shown in Fig.1) will be form near zero degree. To avoid this defect, on one 
hand, antifreeze fluid needs to be optimized, on the other hand, a copper plate pre-cooled 
with liquid nitrogen shall be used for directly contacting skin graft for snap frozen using 
heat conduction style，in order to obtain better cooling effect (as shown in Fig.2).  
At present, there is inadequate researche on the thawing process of frozen skin. Most 
standards advocate rapid warming of the skin to optimise viability. This can be achieved by 
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Fig. 1. Temperature (ºC) curve of skin immersing in liquid nitrogen (Available from: Basic      
and application of skin preservation, people’s military medical publisher;2002.)         
 
 
Fig. 2. Temperature (ºC) curve of skin in a copper plate pre-cooled with liquid nitrogen 
(Available from: Basic and application of skin preservation, people’s military medical 
publisher;2002.)    
immersion of the packs in a 37°C waterbath. The thawing process of skin is closely related to 
previous freezing process. In case of snap frozen, glassy solids are formed inside and 
outside of the cells, and quick rewarming can avoid “devitrification” during temperature 
rise process. “Devitrification”means glassy water or tiny ice crystals-bearing solid water is 
recrystallized prior to thawing, or tiny ice crystals are rethawed into large ice crystals, which 
destroy cell structures and cause cell death(Zieger et al., 1997). 
3. Skin harvesting and processing  
Processing methods used for banking of skin for subsequent therapeutic use depend on 
whether the skin is to retain viability or not. For viable skin grafts, sterilisation techniques 
cannot be applied, however antibiotics and antimycotics may be used to disinfect the tissue 
with respect to bacteria and fungi (Kearney,2005; Li, 2001; Ninnmam et al,.1978).  
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3.1 Screening of donor 
One of the major concerns with the use of skin grafts from donors is the risk of disease 
transmission. A case involving the transmission of HIV from a skin donor to a recipient has 
been reported(Clark, 1987). To reduce the risk of disease transmission, skin donors should 
be screened before skin harvesting. If skin grafts obtained from cadaveric donors，medical 
records held by hospitals, family doctors, and others must be screened for conditions that 
would exclude donation(Delmonico,1998). This may include current systemic infection, 
diseases of unknown etiology, and previous infections with the possibility of current carrier 
status (hepatitis, malaria, HIV, syphilis antibodies etc). It may also be prudent to exclude a 
history of malignant disease particularly if the skin might be used on immunosuppressed 
patients, for example, those suffering massive burn injuries. Behavioral history may also be 
grounds for rejection of the donor owing to the high correlations between activities such as 
intravenous drug abuse and viral infections such as HIV and hepatitis.  
3.2 Reducing the population of microorganism 
Skin tissue possesses a mixed commensal population of bacteria and fungi that lives 
primarily in or around the hair and sebaceous follicles (Kearney et al.,1984). Even the 
commensal bacteria may damage the skin if subsequently allowed to grow during the skin 
storage period to reach massive population densities. Therefore, it is important to try to 
eliminate or minimize the microbial population of skin before retrieval.  
For viable skin allografts, it is not possible to apply a sterilization technique because 
sterilization methods tend to inactivate cells at an equal or greater rate than for the bacterial 
cells. The best that can be achieved is a combination of serology screening for viruses and 
bacterial disinfection using antibiotic cocktails (Holder et al., 1998). This is generally 
achieved using skin prepping techniques similar to those used on the skin of patients 
undergoing operations in hospital. When banking skin in a viable state, it is important to 
validate that the prepping agents have been adequately removed before harvesting the skin, 
and that any residuals are not toxic to the skin cells. Although effective in reducing the 
bioburden, skin prepping is unlikely to totally eliminate bacteria (Lomas et al., 2003). It is 
therefore essential to prevent proliferation of any residual bacteria after retrieval, during 
transportation, and during subsequent processing. Maintaining the skin in a refrigerator or 
at wet ice temperatures prevents the proliferation of most bacteria. To eliminate residual 
bacteria and fungi in viable skin, an antibiotic/antimycotic cocktail may be used. If used at 
reduced temperatures (4Ԩ), the skin may be incubated for up to 24 hours in the cocktail; 
however, only antibiotics that are effective at this temperature should be included. At 
normothermic temperature (37Ԩ), most antibiotics can be considered; however, the 
exposure period should be minimized. 
For nonviable grafts, a range of sterilization techniques can be considered. Dry heat and 
autoclaving damage the structure of the skin tissue, including denaturation of collagen, and 
hence are not suitable. Techniques that have been successfully used include ethylene oxide 
gas and γ irradiation; however, concerns and limitations of these methods are beginning to 
appear. Ethylene oxide gas and its reaction product with chloride—ethylene chlorohydrin—
are very toxic. Although acceptable levels for these compounds had been proposed, more 
recent data suggest that there is no safe level of ethylene oxide with respect to genotoxicity. 
Questions have also been raised about the effectiveness of γ irradiation. Many small viruses 
and spore-forming bacteria are fairly resistant to γ irradiation. The high doses that would be 
required to inactivate HIV in a window-period donor (more than 80 kGy) would cause 
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extensive damage to the tissue matrix including collagen denaturation. Therefore, a current 
consideration is whether “sterilization” can be achieved instead by using combinations of 
microbial inactivation procedures (Kearney, 1989，2005; Prolo et al.,1980).  
3.3 Time control 
Viable skin grafts may be obtained from living donors or, more frequently, from cadaveric 
donors. In the latter case, the skin becomes ischemic immediately after circulatory arrest. 
This leads to progressive cell death over a period of days, which is accelerated at higher 
temperatures. Even if the cadaver is immediately placed into a refrigerator, the body cools at 
a slow rate, leading to at least some warm ischemia time. Nevertheless, viable skin can still 
be retrieved up to circa 24 hours after death. If the body is not quickly refrigerated, the skin 
will be subjected to a much longer warm ischemia period resulting in an accelerated 
deterioration in viability. Once the skin is removed from the body, it can be cooled rapidly 
by immersion into a refrigerated solution, thus immediately reducing the rate of cell death. 
In the other hand, tissue banking standards generally set limits on the maximum warm and 
cold ischemia times permitted after the death of the donor, because it is known that bacteria 
from the gut can be released into the vascular system postmortem and migrate to the 
internal organs and tissues(Kearney, 2005). 
3.4 Sample of preparation skin graft from cadaveric donors 
3.4.1 Donor selection 
Donor skin procurement must comply with local legislation. To ensure skin grafts quality, 
donors were aged between 8–60 years. The exclusion criteria for harvesting skin are 
basically the same as for donors of parenchymatous organs. Further exclusion criteria 
comprise skin diseases, injuries in the areas from which skin may be harvested, and blood 
samples were tested for HIV, HbA, HbB, HbC and syphilis antibodies. 
3.4.2 Skin harvesting 
Skin is cleaned with povidone-iodine 10% solution and skin with adipose layer harvested 
with a knife. Areas from which skin is harvested are limited to the following regions: ventral 
and dorsal trunk, left and right upper arm, and left and right thigh. Immediately after the 
removal, grafts were placed in saline, refrigerated and transferred to the processing room. 
The hair was removed and skin was soaked in 0.1% benzalkonium bromide for 15 min to 
sterilize. Split skin of 0.2–0.3mm was harvested under sterile conditions by a dermatome. 
Thereafter split skin was washed extensively and soaked for 10 min 3 times in saline with 
Penicillin /Streptomycin; then in Neomycin–saline (0.5%) for 10 min, 3 times. All the 
following procedures are carried out under sterile conditions. 
3.5 Sample of preparation skin graft from porcine 
Domestic pigs were sacrificed and the skin was washed extensively with soap and water. 
The hair was removed by razor and the carcass was cleaned with povidone-iodine 10% 
solution. After cleaning, 0.3 mm to 0.6 mm partial-thickness skin from the pig`s back was 
harvested with a dermatome. Immediately after the removal, the harvested skins were 
placed into sterile boxes in normal saline supplemented with penicillin/streptomycin and 
sent to the laboratory, then soaked in 0.1% benzalkonium bromide for 15 min to sterilise and 
rinsed thrice in normal saline supplemented with penicillin/streptomycin in a laminar flow 
hood (Chiu&Burd, 2005). 
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4. Viable skin grafts preservation 
Fresh cadaver allograft is still considered the ‘gold standard’ biologic dressing for closure of 
burns. Unfortunately, the use of fresh allografts is severely impeded by their inadequate 
availability. Skin graft preservation for the purpose of delayed application is still a basic tool 
in burn treatment and plastic and reconstructive surgery. Even if the skin is placed into an 
oxygenated nutrientrich medium, ischemic necrosis of the tissue still occurs because the 
diffusion path from the tissue periphery to the central cells is extensive, oxygen and 
nutrients cannot diffuse fast enough to supply the cells, and toxic metabolites cannot be 
removed quickly enough. Therefore, method for the viable storage of skin is to reduce the 
temperature hence reduces the metabolic rate of the cells and the nutritional demands and 
metabolite production (Bravo et al,. 2000; Ge et al., 2010; Robb et al., 2001; Sterne et al., 2000). 
4.1 Storage in 4°C 
As early as 1903, Wentscher reported the successful storage and grafting of skin autografts 
at temperatures near 0Ԩ for 14 days (Wentscher, 1903). Further studies by Carrel using 
normothermic and hypothermic storage conditions confirmed the utility of the latter (Carrel, 
1912). Eventually, refrigerator storage for skin autografts became the norm in burn units. 
The simplest technique was to fold the skin so that the cut surfaces were in apposition and 
then wrap the skin sandwich in tulle gras and/or saline gauze to prevent desiccation. Using 
this method, autologous skin can be used after around 2 weeks of storage, although cell 
viability is very low at this point. Unlike autograft, allograft has already lost some viability 
by the time it is retrieved; therefore, maximum storage times using this method are reduced 
to 7 or 8 days. Many attempts have been made to extend the refrigerator storage period for 
skin. The addition of homologous serum at 10% to 33% was found to be beneficial because it 
provided nutrients and diluted and buffered acids produced as byproducts of metabolism 
(Allgower & Blocker, 1952). Alternatively, tissue culture media as a source of nutrients and 
various buffering systems have been evaluated. The buffering systems, however, only 
extend slightly the period of useful storage. Different methods for storing skin grafts around 
4Ԩ are shown in Table 1 and show a large variance in storage time although the storage 
methods are similar. The main reason for this variance may be criteria incompatible and the 
absence of reliable detection methods of early research especially before 1970. The storage of 
skin grafts in a 4Ԩ refrigerator is a simple and practicable technique; however, the skin 
showed a very slow viability decrease with time stored at 4Ԩ (Chang et al., 1998; DeBono et 
al., 1998; DeLW, 1980; Matsuka et al., 1993; May & Wainwright, 1985). The preservation time 
of fresh skin should not exceed 3 days when stored in normal saline and must be used 
within two weeks even when stored in tissue culture media with 10% serum.  
4.2 Storage in -20°C  
Wang has success develop non-freeze complex cryoprotectants( 10% DMSO, 10% propylene 
glycol，10% PEG，10% glycerin) to avoid ice crystal formation when skin stored in -
20Ԩ，the skin remain 76% activity in 14th day, higher than that of stored at liquid 
nitrogen˄60-70%˅, then skin activity lower than that of stored at liquid nitrogen in the 
following time, but still remain 50% viability(the ultimate rate to survival post-
transplantation) in 60 days, so skin grafts stored at -20Ԩ should be first consider if skin will 
be used within 2 weeks.(Wang et al., 2002). 
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Year Author Category Stored method Stored time 
1903 Wentsch Human Exsiccatus ice-box 3-14d 
1912 Carrel chicken 
0Ԩ, normal saline with serum, 
paraffin oil 
Several weeks 
1912 Carrel Dog 0Ԩ, normal saline，blood Several months 
1922 Filatov Human 0Ԩ Several days 
1945 Matthews Human 
3-6Ԩ，normal saline，oxygen 
deficiency 
3-8 weeks 
1949 Hanks，Wallace Rabbit 0-8Ԩ，10% serum 2 weeks 
1952 Allgower，Blocker Human 5Ԩ,10% serum 14 days 
1952 Hyatt Human 4Ԩ,10% serum 185 days 
1954 Skoog Rat 3Ԩ 3 weeks 
1957 Perry Human 4Ԩ，Earle medium，10% serum 84 days 
1963 Grasham Human 4Ԩ，10% serum 6-8 weeks 
1971 Bondoc，Burke Human 4Ԩ，serum 14 days 
1972 Lawrene Human 4Ԩ，normal saline 1 week 
1985 May，Wainwright Pig 4Ԩ，Earle medium 1 week 
2002 Alotto Human 
4Ԩ，RPMI 1640, 1% human serum 
albumin 
72 hours 
2003 Castagnoli Human 
4Ԩ，RPMI 1640, 1% human serum 
albumin 
4 days 
2010 Ge Pig 4Ԩ，normal saline or DMEM 72/96hours 
Table 1. Effect of skin stored around 4Ԩ 
4.3 Deep freezing 
Deep freezing is preservation of skin grafts in ultra-low temperature refrigerator, which 
generally maintain temperature under -80Ԩ，and now -150Ԩ ultra-low temperature 
refrigerator has been made in China. The advantage of this method is simplicity of operator, 
low maintain cost and relative long preservation time (not exceed 1 year) (May et al., 1985, 
1988). 
To achieve high viability of skin grafts, cryoprotective agents (CPAs) should be added 
before freezing. The general properties of cryoprotectants are that the molecules can pass 
through the cell membrane into the cell and be relatively nontoxic at very high multimolar 
concentrations. Several cryoprotective chemicals have been identified. CPAs are glycerol 
and dimethyl sulfoxide. Cryoprotective agents are able to prevent solution effect injury. 
CPAs mode of action is probably 2-fold. First, they act as solvents for the salt, thus reducing 
the salt concentration that the cells are subjected to at the high subzero temperatures (where 
solution effects are most damaging). Secondly, the presence of CPAs within the cells prevent 
excessive shrinkage of the cells during this cooling phase. Therefore, in the presence of 
CPAs, it is possible to use very slow cooling rates that minimize intracellular ice formation 
while protecting the cells against solution effects. High viabilities of all cell types can thus be 
achieved using this slow cooling rate.  
Although CPAs are relatively nontoxic at low temperatures, the toxicity can become 
significant at higher temperatures. In addition, the rate at which CPAs enter the cells is 
temperature and CPA dependent, being faster at higher temperatures. Therefore, the 
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optimum temperature and the exposure time need to be validated. The basal medium into 
which the CPA is dissolved for incubation of the skin tissue should be a balanced salt 
solution, in which the zwitterionic buffers hydroxyethyl piperazine ethanesulfonic acid 
(HEPES) and trimethylamino-ethanesulfonic acid (TES) have been shown to work well 
(Basaran et al., 2006). To avoid osmotic lysis of the cells, either the saline can be added 
gradually or an impermeant solute such as sucrose can be added to the saline to reduce the 
difference in osmolarity. 
4.4 Cryopreservation 
A better method for the long-term preservation of skin grafts is cryopreservation. The 
cryopreservation technique facilitates the cooling of the tissues to ultralow temperatures 
while protecting the viability of the cells (Aggarwal et al., 1985; Bondox & Burke, 1971; Cui 
et al., 2007; Fujita et al., 2000; Marrel et al., 1986). Once the skin is at a temperature lower 
than -130Ԩ, no further loss of cell viability is incurred. The boiling point of nitrogen gas is -
196Ԩ, so skins immersed into liquid nitrogen should be able to keep viabily indefinitely in 
abstracto.  
There are two different cryopreservation protocols used in skin preservation: slow freezing 
and quick freezing/snap frozen. Slow freezing can be achieved using a controlled-rate 
cooling apparatus (Blondet et al., 1982).  There is an optimum cooling rate for any cell type 
that produces maximum cell survival. On either side of this optimum, the survival rate falls. 
In the presence of CPA, a cooling rate of -1 ºC per minute will ensure survival of most of the 
cells within skin tissue. As the cooling rate is increased，cell populations are sequentially 
and adversely affected. Many cells in the body derived from leukocytes or closely related 
lineages are known to be exquisitely sensitive to cryogenic injury. The depletion of 
immunostimulatory “passenger leukocytes” was demonstrated by increasing the cooling 
rate for pancreatic islets of Langerhans while maintaining the viability of the insulin-
producing islet cells (Ingham et al., 1993). This concept of cooling rate–dependent 
immunomodulation was evaluated for skin tissue. A cooling rate of -30Ԩ/min was shown 
to maintain the viability of keratinocytes and fibroblasts while reducing the immunogenicity 
(as assessed by the mixed epidermal cell/lymphocyte response assay) of murine allografts 
by 95%. This was assumed to be due to an effect of the faster cooling rate on the major 
immunostimulatory cell in the skin—the Langerhans cell. 
Quick freezing/snap frozen is skin vitrification technique. Vitrification is defined as “the 
instant solidification of a solution brought about by an extreme elevation in viscosity during 
cooling, without ice crystal formation”. In other words, vitrification is faster and lacks some 
of the typical disadvantages seen in traditional slow freezing (Mukaida, 2003). It bypasses 
the ice-crystal formation phase and instantaneously solidifies into a glass-like structure, 
moves the water directly into a glass-like phase. In a glass, the molecules do not rearrange 
themselves into grainy ice crystals as the solution cools, but instead become locked together 
while still randomly arranged as in a fluid, forming a “solid liquid” as the temperature falls 
below the glass transition temperature (Silvestre et al., 2002). This technique was simple, 
and no expensive equipment was needed. Initially, this method needed a 2-step procedure 
because the cryoprotective agent was toxic. Kasai et al., (1990) modified this impractical to a 
1-step method and incubated the skin with vitrification solution at room temperature and 
was transferred directly into liquid nitrogen.  
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Ben-Bassat et al., (1996, 2001) evaluation graft performance of cryopreserved cadaveric skin 
by programmed freezing (1°C/min). The results demonstrate that graft performance of 
cryopreserved skin decreased with time as seen in the lower percent of samples with high 
scores of separate histologic criteria after prolonged storage (Ben-Bassat et al., 1996). 
Nevertheless, paired comparison analysis between cryopreserved and fresh skin indicated 
that this decrease was not significant for storage of 5 years; however, it was highly 
significant for 6 years of storage (Ben-Bassat et al., 2001).  
Table 2 shows the distinction of different preservation and the viability of skin frozen at -
20Ԩ attenuated to 50% (the ultimate rate to survival post-transplantation) in 60 days. Skin 
grafts stored at -20Ԩ should be used within two months. To be similar, the skins should be 
transplanted in one year of freezing in -80Ԩ and 5 years in liquid nitrogen. Viability declines 
rapidly after thawing of the skin and further storage before use cannot be recommended. 
 
 
Commom 
refrigerator 
Freezer 
ultra-low temperature 
refrigerator 
Liquid 
nitrogen 
Temperature(Ԩ) 4 -18～-20 -80 -196 
Equipment cost Cheap Cheap Costly moderately 
Sustain cost Cheap Cheap Cheap Costly 
Electricity effect Great Great Great None 
Storage time 3～7days 60days 1 year 5 years 
ViabilityȐ%ȑ 30～80 50～60 50～60 60～70 
Table 2. Comparison of different preservation methods 
5. Nonviable skin grafts preservation 
With non-viable skin (or dermis) there is no requirement to maintain the viability of tlhe 
skin cells. Nevertheless, it is still important that degradative changes do not adversely affect 
the tissue matrix and bacteria are not allowed to proliferate; therefore, many of the practices 
discussed earlier will still apply. A major difference from viable skin, however, is that much 
more effective disinfection or sterilisation methods can be applied to the skin, including 
virucidal treatments.  
5.1 Freeze drying 
In the early 1950s, the US Navy Tissue Bank was the first to commence large-scale freeze 
drying of human tissues for implantation. In 1955, the use of freeze-dried skin was first 
reported (Brown et al., 1955). It was subsequently shown that freeze drying reduced the 
immunogenicity of skin without interfering with its beneficial propertiesȐAbbott & 
Hembree , 1970ȑ.This process involves the removal of water from skin in the frozen state 
by sublimation, which is achieved by applying a vacuum to the tissue and condensing the 
removed water molecules downstream. Sublimation from the frozen state helps to protect 
molecules that would otherwise be adversely affected by high salt concentrations at higher 
temperatures, for example, denaturation of proteins. Drying must continue until enough 
water has been removed to prevent degradation reactions, which equates to less than 5% 
residual water as measured gravimetrically. Although accepted in most tissue banking 
standards, “residual water” is not identical to “water activity”, which is the most 
appropriate measure. 
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5.2 Glycerolization preservation 
In 1980s, glycerin was applied in clinical practice as skin graft preservation fluid, and had 
very good effect (Hermans, 1989; Huang et al., 2004; Richter et al., 1997; Van Baare et al., 
1994,1998; Vuola & Pipping, 2002). EuroSkin Bank has done considerable fruitful work in 
the area and developed a solute preservation method using glycerol (De Backere & Mackie, 
1997; Mackie, 1997). The skin was incubated in successively more concentrated glycerol 
solutions (50%, 70%, and 85%) and maintained long term in 85% glycerol. More recently, the 
glycerol and water flux kinetics have been characterized and a more efficient validated 
protocol was proposed. Study demonstrated that the 85% concentration originally chosen by 
the Euroskin Bank is optimal for minimizing degradative reactions (Ross & Kearney, 2004). 
It is very important that the glycerol is removed from the skin before clinical use. Failure to 
remove glycerol may lead to high systemic concentrations when used on open wounds. This 
is achieved by repeatedly washing the skin in physiological saline, and at least 30 to 60 
minutes are required to remove most of the glycerol.  
5.3 Glutaraldehyde preservation 
As early as 1975, Schetnter reported the successful grafting of glutaraldehyde- preserved skin 
in clinical (Schetnter, 1975). The morphology of skin grafts has not evident change after treated 
with glutaraldehyde, and skin antigenicity was greatly reduced because antigen determinant 
site was closed by cross-linking of protein in the skin grafts. Glutaraldehyde-treated skin grafts 
can be used for escharectomy and tangential excision wounds and granulation wound 
covering, and has been shown to promote the formation of granulation tissues. However, such 
skin grafts have least elasticity, that is, with the extension of preservation duration, the skin 
becomes harder. Fresh allograft skin or lyophilized skin shall be immersed in 0.5% 
glutaraldehyde solution for 7-20min and be washed with normal saline for three times prior to 
use. There is no evident change in the elasticity and softeness of such skin, but its antignicity is 
decreased, which helps to extend the adhesion duration of grafted skin.  
5.4 Irradiation preservation 
Irradiated porcine skin is the most commonly used burn wound covering in China. Fresh 
porcine skin graft is sealed in a plastic bag and is irradiated with 60Co or an accelerator, then 
put into an ordinary refrigerator for preservation. After being irradiated, porcine skin can 
achieve integral asepsis, and its antignicity can be decreased. For gamma irradiation, the most 
resistant microorganisms are viruses, D10-values as high as 13 KGy have been reported for 
certain small viruses. Application of the commonest used dosage (25 KGy) to these viruses 
would only reduce the bioburden by 2 logs10. The high doses that would be required to 
inactivate HIV in a window-period donor (more than 80 kGy) would cause extensive damage 
to the tissue matrix including collagen denaturation. There are two possible effects on the 
macromolecular structure of skin matrix resulting from ionising irradiation. The first is 
scission which results in the breaking of bonds thus weakening the matrix. In the presence of 
water a second process involves crosslinking by new bond formation resulting from the 
generation of free radicals which may lead to stiffening of the matrix.  
6. Quality control 
A variety of national/international organisations have issued standards or guidelines for 
tissue banking, including the National Blood Service, British Association for Tissue Banking, 
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and European Association of Tissue Banks, etc (Baxter, 1985; Ben-Bassat et al., 2000; British 
Association for Tissue Banking, 2011; Chua et al., 2004; European Association of Tissue 
Banks, 2011; Freedlander et al., 1998; Janezic, 1999; Kalter, 1997; Kearney, 1998; May, 1990; 
Pillipp et al., 2004; Pianigiani et al., 2005). The core principle of skin banking quality control 
is to avoid the risk of cross infection and provide high-quality skin grafts for clinical. 
Therefore, donor selection, microbial/viral tests, skin viability detection and transplantation 
performance will be discussed in this paper. 
6.1 Donor selection 
With respect to medical/behavioural history screening, the regulatory and standards 
documents are once again very specific with a good deal of international consensus. Sources 
of medical/behavioural information include the next of kin (or partner/close friend) of the 
deceased who must be interviewed regarding medical history and any factors, practices or 
behaviour that may have increased the risk of exposure to HIV/Hepatitis. In addition, the 
family doctor, hospital records, and autopsy report should be consulted as additional 
sources of medical and behavioural history. Evaluation of the risk of virus exposure must be 
explored in detail with other aspects of medical and behavioural history. The exclusion 
criteria for harvesting skin are basically the same as for donors of parenchymatous organs 
including cancer, diseases of unknown aetiology and various viral, bacterial and parasitic 
diseases. Further exclusion criteria comprise other skin diseases and injuries in the areas 
from which skin may be harvested. 
6.2 Microbial/viral tests 
There is a widespread consensus on the testing of donors to preclude certain virological 
diseases, including HIV, Hepatitis B, Hepatitis C, syphilis antibodies ,and in general these 
follow the National Blood Service testing regimens for each country. Screening for CMV is 
important when recipients are CMV negative and will receive immunosuppressive drugs 
following organ transplantation. However, the natural immunosuppression associated with 
burns does not appear to lead to CMV related problems in skin allograft recipients. Many 
tissue banks do not screen for CMV. The microbial tests are generally done on allograft 
samples and the viral tests on blood samples.Skin samples for microbial tests are incubated 
in Thioglycollate and Roswell Park Memorial Institute (RPMI) 1640 without antibiotics, in a 
37Ԩ incubator for 10 days. 
6.3 Skin viability 
The viability of graft skin is fundamental for surgical procedures involving graft taking, and 
the American Association of Tissue Banks indicates that the viability of skin is an essential 
prerequisite for good-quality grafts (American Association of Tissue Banks, 2011). It is a 
necessity that a skin bank should certify, not only the sterility, but also the viability of the 
skin allografts used and that routine quality controls be carried out to certify that grafts are 
viable before transplantation. The of viability assays is two-fold: one is that of supplying an 
‘‘experimental assay’’: used to optimize the various parts of a preservation procedure 
during experimental development. The other offers a ‘‘predictive assay’’: used to predict the 
‘‘quality’’ of an individual sample that has been stored by an established tested technique. 
Various methods, both qualitative and quantitative, are currently used to determine skin 
grafts viability such as cell culture, succinate dehydrogenase, trypan blue dye, skin oxygen 
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consumption, Tetrazolium salts (MTT/WST-1), SYTO/EB dyes and so on (Alotto et al., 
2002). The MTT method is most widely used because it is simple, quick and precise 
(Castagnoli et al., 2003; Klein, 1996; Pegg, 1989; Yang et al., 2000; Zieger et al., 1993). 
6.4 Transplantation performance 
Skin transplantation experiment is a straightforward and reliable skin graft quality 
evaluation method. For any skin graft and preservation method, the final result is to identify 
that the skin graft can survive in the living body. For  evaluation of transplantation 
performance of preserved skin, samples of skin were often grafted onto mice and rats and 
the experiment animals were sacrificed after 4 or 7 days. The grafts were then assessed by 
gross inspection including adherence to wound bed, color and pliability and by histologic 
evaluation including epidermis integrity, epidermal–dermal junction, collagen organization, 
the presence of fibroblasts and graft adherence (Cinamon et al., 1993).  
7. Conclusions 
Skin graft preservation for the purpose of delayed application is still a basic tool in burn 
treatment and plastic and reconstructive surgery. It is therefore important to provide a 
framework for selecting optimal guidelines for procurement, processing, preservation, and 
quality control of skin grafts for doctors and researchers, thus ensuring high levels of safety 
and efficacy of skin grafts. 
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